Your Unread Messages
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Mitigation of indomethacin-induced gastric mucosal lesions by a potent specific type V phosphodiesterase inhibitor
World Journal of Gastroenterology, 11/02/09
Karakaya K et al. – Vardenafil affords a significant dose–dependent protection against indomethacin induced gastric mucosal lesions.
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Joint Extraintestinal Manifestations in Ulcerative Colitis
Digestive Diseases, 11/09/09
The liver in 30-year-old individuals with alpha 1 -antitrypsin deficiency
Scandinavian Journal of Gastroenterology, 11/06/09
Caspase-cleaved fragments of cytokeratin 18 - the promises and challenges of a biomarker for chronic liver disease
Alimentary Pharmacology and Therapeutics, 11/03/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Safety Profile of IBD: Lymphoma Risks
Gastroenterology Clinics of North America, 11/16/09
Methotrexate for maintenance of remission in Crohn's disease
Cochrane Reviews, 10/27/09
Monotherapy versus combination therapy for the treatment of chronic hepatitis B
Expert Opinion on Investigational Drugs, 10/26/09
Sponsor
Article Search
Sponsor


See All



